Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ad-hoc News: SMA Solar Technology AG (EQS) +++ SMA SOLAR Aktie -8,68%

Gewinn & Umsatz News zur CHARLES RIVER Aktie

 >CHARLES RIVER Aktienkurs 
139 EUR    -0.5%    (Tradegate)
Ask: 140.35 EUR / 72 Stück
Bid: 139 EUR / 73 Stück
Tagesumsatz: 37 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>CHARLES RIVER Performance
1 Woche: +4,3%
1 Monat: -9,3%
3 Monate: +16,3%
6 Monate: -12,3%
1 Jahr: -22,4%
laufendes Jahr: -21,0%
>CHARLES RIVER Aktie
Name:  CHARLES RIVER LAB.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US1598641074 / 939391
Symbol/ Ticker:  RV6 (Frankfurt) / CRL (NYSE)
Kürzel:  FRA:RV6, ETR:RV6, RV6:GR, NYSE:CRL
Index:  S&P500
Webseite:  http://www.criver.com
Profil:  Charles River Laboratories International, Inc. pro..
>Volltext..
Marktkapitalisierung:  6878.05 Mio. EUR
Unternehmenswert:  9127.68 Mio. EUR
Umsatz:  3447.61 Mio. EUR
EBITDA:  776.87 Mio. EUR
Nettogewinn:  -59.24 Mio. EUR
Gewinn je Aktie:  -1.12 EUR
Schulden:  2386.74 Mio. EUR
Liquide Mittel:  156.8 Mio. EUR
Operativer Cashflow:  673.89 Mio. EUR
Bargeldquote:  0.17
Umsatzwachstum:  -10.17%
Gewinnwachstum:  -114.39%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 186.096 USD.
Suchwörter:  CHARLES RIVER
Letzte Datenerhebung:  01.09.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 49.21 Mio. St.
Frei handelbar: 98.88%
Rückkaufquote: 5.72%
Mitarbeiter: 20100
Umsatz/Mitarb.: 0.17 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 6.23%
Bewertung:
KGV: -
KGV lG: 16
KUV: 1.99
KBV: 2.41
PEG-Ratio: -
EV/EBITDA: 11.75
Rentabilität:
Bruttomarge: 29.96%
Gewinnmarge: -1.72%
Operative Marge: 11.86%
Managementeffizenz:
Gesamtkaprendite: -0.89%
Eigenkaprendite: -1.96%
>Peer Group

Es sind 601 Aktien bekannt.
 
27.08.25 - 16:30
 Charles River Laboratories Stock: Analyst Estimates & Ratings (Barchart)
 
Despite Charles River Laboratories' weak performance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock's prospects....
06.08.25 - 15:18
 Charles River Laboratories International Inc. Profit Drops In Q2 (AFX)
 
WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) revealed earnings for second quarter that Drops, from the same period last yearThe company's earnings came in at $52.32 m......
18.07.25 - 14:18
 Here€s What to Expect From Charles River Laboratories€ Next Earnings Report (Barchart)
 
Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company's bottom-line figure....
07.05.25 - 15:18
 ROUNDUP: Charles River Boosts FY25 Outlook; Stock Up 22% On Strategic Review Announcement (AFX)
 
WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) raised its earnings, adjusted earnings, revenue gr......
07.05.25 - 13:48
 Charles River Laboratories International Inc. Q1 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) revealed earnings for first quarter that decreased from last year but beat the Street estimates.The company's earnings to......
28.04.25 - 18:30
 Earnings Preview: What To Expect From Charles River Laboratories€ Report (Barchart)
 
Charles River Laboratories is scheduled to announce its first-quarter results next week, with analysts anticipating a single-digit earnings dip....
26.02.25 - 10:48
 Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
 
Charles River Laboratories has lagged behind the broader market over the past year, with Wall Street analysts maintaining a cautious outlook on its future performance....
19.02.25 - 13:42
 Charles River Laboratories International Inc. Q4 Earnings Summary (AFX)
 
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Charles River Laboratories International Inc. (CRL):Earnings: -$214.50 million in Q4 vs. $187.08 million in the same period last year. ......
24.01.25 - 13:54
 Charles River Laboratories€ Quarterly Earnings Preview: What You Need to Know (Barchart)
 
Charles River Laboratories will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth....
06.11.24 - 13:31
 Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) announced earnings for third quarter that decreased from the same period last year but beat the Street estimates.The comp......
07.08.24 - 19:19
 Charles River falls after cutting yearly profit, revenue forecast, flags soft demand (Reuters EN)
 
Charles River falls after cutting yearly profit, revenue forecast, flags soft demand...
07.08.24 - 16:44
 Charles River Laboratories International Inc reports results for the quarter ended in January - Earnings Summary (Reuters EN)
 
Charles River Laboratories International Inc reports results for the quarter ended in January - Earnings Summary...
07.08.24 - 13:54
 ROUNDUP: Charles River Laboratories Slashes FY24 Outlook (AFX)
 
WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) slashed its earnings, adjusted earnings, revenue ......
07.08.24 - 13:37
 Charles River Laboratories International Inc. Q2 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) announced earnings for second quarter that decreased from the same period last year but beat the Street estimates.The com......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Fast jeder Beruf ist mehr als Beruf: Eine leichte Krankheit, ja Verrücktheit der Seele. - Charles Tschopp
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!